aibio
Listings ·
Milestone Pharmaceuticals falls below Nasdaq's $1.00 minimum bid rule
Milestone has until April 21, 2027 to close at $1.00 or more for 10 consecutive business days, after 30 consecutive business days below that level.
MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals (MIST) news MIST offering news
Latest Milestone Pharmaceuticals news
- Financings
Milestone Pharmaceuticals lifts Jefferies at-the-market program to up to $77,800,000
Milestone amended its Jefferies sales agreement to allow up to $75,000,000 of new common shares, within a $77,800,000 total that includes about $2.8 million already sold. Jefferies can earn up to 3.0% commission, and the shares closed at $2.41 on March 17, 2025.
Milestone Pharmaceuticals annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.5 million | $0 |
| Research and development | $18.1 million | $14.4 million |
| Net income (loss) | -$63.1 million | -$41.5 million |
| Cash from operations | -$49.0 million | -$28.8 million |
| Cash and equivalents | $73.0 million | $25.3 million |
| Short-term investments | $32.9 million | $44.4 million |
Questions about Milestone Pharmaceuticals
Has Milestone Pharmaceuticals raised money recently?
Our latest story on this, dated Mar 18, 2025: "Milestone Pharmaceuticals lifts Jefferies at-the-market program to up to $77,800,000". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Milestone Pharmaceuticals?
Milestone Pharmaceuticals Inc. trades under the ticker MIST on NASDAQ.
Where is Milestone Pharmaceuticals listed?
Milestone Pharmaceuticals Inc. is listed on NASDAQ.
What is the SEC CIK of Milestone Pharmaceuticals?
The SEC Central Index Key (CIK) for Milestone Pharmaceuticals Inc. is 1408443. Its filings are on SEC EDGAR.
How many shares does Milestone Pharmaceuticals have outstanding?
124,497,980 shares as of 2026-08-12, per the cover page of its 10-Q filed 2026-08-12.
Which country or territory is Milestone Pharmaceuticals listed under?
Our directory records Milestone Pharmaceuticals Inc. under Canada.
What does Milestone Pharmaceuticals do?
Our directory classifies Milestone Pharmaceuticals Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Milestone Pharmaceuticals?
The ISIN recorded for Milestone Pharmaceuticals Inc. is CA59935V1076.
Does aibio.space cover Milestone Pharmaceuticals?
aibio.space lists Milestone Pharmaceuticals Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Milestone Pharmaceuticals incorporated?
SEC records list its state or country of incorporation as A8.
What was Milestone Pharmaceuticals's revenue last year?
$1.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Milestone Pharmaceuticals profitable?
Milestone Pharmaceuticals Inc. reported a net loss of $63.1 million for the fiscal year ended Dec 31, 2025, and used $49.0 million of cash in operations, per its annual report to the SEC.
How much does Milestone Pharmaceuticals spend on research and development?
$18.1 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Milestone Pharmaceuticals have?
$170.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
What is the latest Milestone Pharmaceuticals (MIST) stock news?
Our latest story on Milestone Pharmaceuticals, dated Oct 28, 2026: "Milestone Pharmaceuticals falls below Nasdaq's $1.00 minimum bid rule". Milestone has until April 21, 2027 to close at $1.00 or more for 10 consecutive business days, after 30 consecutive business days below that level. Source.
Investor discussion: Milestone Pharmaceuticals
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
SEC filings and registration
- SEC name
- Milestone Pharmaceuticals Inc.
- CIK
- 1408443
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- MIST (Nasdaq)
- State or country of incorporation
- A8
- Fiscal year ends
- December 31
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- Phone
- (514) 336-0444
- Shares outstanding
- 124,497,980 as of 2026-08-12 (10-Q filed 2026-08-12)
Recent filings
Listing details
- Company
- Milestone Pharmaceuticals Inc.
- Ticker
- MIST
- Listing
- NASDAQ
- Country or territory
- Canada
- Business scope
- Pharmaceuticals: Major
- ISIN
- CA59935V1076
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction